Toss-Up Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 3.00 M
- Paid Up Capital ₹ 3.00 M
- Company Age 4 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 482.42%
- Profit Growth 546.60%
- Ebitda -2148.03%
- Net Worth 35.09%
- Total Assets 99.45%
About Toss-Up Pharmaceuticals
Toss-Up Pharmaceuticals Private Limited (TPPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 26 November 2020 (Four years and two months 9 days old ). Its registered office is in Jaipur, Rajasthan, India.
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.00 M and a paid-up capital of Rs 3.00 M, as per Ministry of Corporate Affairs (MCA) records.
Ravi Suman and Rajiv Singh serve as directors at the Company.
Company Details
-
Location
Jaipur, Rajasthan, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U51909RJ2020PTC072274
-
Company No.
072274
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
26 Nov 2020
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Jaipur
Industry
Who are the key members and board of directors at Toss-Up Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ravi Suman
|
Director | 26-Nov-2020 | Current |
|
Rajiv Singh
|
Director | 26-Nov-2020 | Current |
Financial Performance of Toss-Up Pharmaceuticals.
Toss-Up Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 482.42% increase. The company also saw a substantial improvement in profitability, with a 546.6% increase in profit. The company's net worth Soared by an impressive increase of 35.09%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Toss-Up Pharmaceuticals?
Unlock access to Toss-Up Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Endear Life Science Private LimitedRavi Suman and Rajiv Singh are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Toss-Up Pharmaceuticals?
Toss-Up Pharmaceuticals has a workforce of 11 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Toss-Up Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Toss-Up Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.